📢📢📢 Portfolio News: Supira Medical Launches U.S. Early Feasibility Study! We're excited to share that the first U.S. patient has been treated using Supira Medical's transformative low-profile, high-continuous-flow percutaneous ventricular assist device (pVAD) at Piedmont Heart Institute in Atlanta, Georgia. The milestone case was performed under the expert care of Dr. David Kandzari and his team. With over 70 patients treated across South American clinical sites to date, this achievement marks an important step in expanding the clinical evidence base for Supira’s breakthrough technology in the United States. 🍾🍾🍾 Congratulations to the teams at Supira Medical and Shifamed for this remarkable achievement. Your innovation and commitment continue to drive transformative outcomes for patients worldwide! cc: Nitin Salunke, Amr Salahieh
Supira Medical is pleased to announce the launch of its U.S. Early Feasibility Study. Thank you to Dr. David Kandzari and the entire clinical team for their tireless efforts to achieve this important milestone. We look forward to enrolling subsequent patients and expanding to additional sites. Read the full press release here: https://lnkd.in/eZvvbmHY. The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S. #pVAD #innovation #medtech #makingadifference David Kandzari, Gagan Singh, Nitin Salunke, Nicole Haratani, Veronica Neiman
